English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18269/20496 (89%)
Visitors : 9950318      Online Users : 1062
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/29618


    標題: Sex Difference for Urologic Malignancy Risk in Uremic Patients After Kidney Transplantation: A Population-based Study
    作者: Hwang, Jyh-Chang
    Jiang, Ming-Yan
    Lu, Yi-Hua
    Weng, Shih-Feng
    貢獻者: 醫務管理系
    關鍵字: stage renal-disease
    transitional-cell carcinoma
    urinary-tract
    urothelial carcinoma
    dialysis patients
    cancer
    taiwan
    recipients
    multicenter
    experience
    日期: 2015-04
    上傳時間: 2016-04-19 19:02:13 (UTC+8)
    出版者: Lippincott Williams & Wilkins
    摘要: Background. High urologic malignancy incidence has been reported in end-stage renal disease (ESRD) patients, especially of female sex. This study was undertaken to evaluate whether female recipients still carry an aggravated risk of this malignancy after kidney transplantation (KT). Methods. The claims data from the Bureau of National Health Insurance of Taiwan were used for analysis. All KT recipients who developed urologic malignancy from January 1, 1999, to December 31, 2007 (n = 2,245) were enrolled in this study. By means of propensity score, a database of 1: 4 ratio random incident ESRD patients with matched age, sex, comorbidity rates, and dialysis to index date was used as control (non-KT group, n = 8,980). The last observation period ended on December 31, 2008. Results. The cumulative urologic malignancy incidence rate was significantly higher in female recipients after KT than their female ESRD counterparts without KT (P < 0.001). This gap became more prominent approximately 2 years after transplantation. No similar trend was detected in male KT patients (P = 0.13). Incidence rate ratio of urologic malignancy was significantly higher in female recipients (incidence rate ratio, 2.13; 95% confidence interval [95% CI], 1.53-2.97) than in their male counterparts (incidence rate ratio, 1.43; 95% CI, 0.90-2.25). From multivariate Cox proportional hazard regression tests, female (hazards ratio, 2.10; 95% CI, 1.52-2.95) but not male sex (hazards ratio, 1.47; 95% CI, 0.93-2.32) was determined to be an independent factor for the development of urologic malignancy after KT. After acquiring this malignancy, KT recipients did not have any advantage in cumulative survival compared to ESRD patients without KT (P = 0.07). Conclusion. Compared to males, female recipients tended to have a significantly higher urologic malignancy risk after KT.
    關聯: Transplantation, v.99 n.4, pp.818-822
    Appears in Collections:[醫務管理系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML1506View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback